Conclusion of non-exclusive drug rebate agreement pursuant to § 130a section 8 SGB V via an open-house model for the active ingredient epinephrine (ATC code according to WHO: C01CA24) in the form of nasal spray
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Epinephrin (ATC-Code nach WHO: C01CA24) in der Darreichung Nasenspray
Germany · Erfurt
What the buyer is looking for
Siehe Kurzbeschreibung
Description as published (DE).
Contract
BuyerAOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
TypeSupplies
Estimated valuevalue not published
Published31 July 2026
CategoryMedical equipment & pharma · CPV 33600000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Hexal AG · Holzkirchen | 45 | 2013–2024 |
| Aliud Pharma GmbH · Laichingen | 41 | 2013–2021 |
| ratiopharm GmbH | 37 | 2016–2024 |
| betapharm Arzneimittel GmbH · Augsburg | 35 | 2013–2021 |
| axicorp Pharma B.V. · EC Den Haag | 30 | 2016–2021 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
2019282
2020224
2021274
2022178
2023247
2024285
2025539
2026219
Who knows the rhythm prepares instead of reacting.
407
days until the deadline — Thursday 30 September at 21:58
How to bid
Read the full notice — Original + documents
Goes directly to this tender on Öffentliche Vergabe (Datenservice). The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →